Compelling new data on the effectiveness of Australia's National Bowel Cancer Screening Program: A model for best practice?

Asia-Pacific Journal of Clinical Oncology

Volumn 12, Issue 1, 2016, Pages 7-9

  John, James St ^a,b   Grogan, Paul ^c  

^a CANCER EPIDEMIOLOGY CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CANCER COUNCIL AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; EDITORIAL; HIGH RISK PATIENT; HUMAN; IMMUNOCHEMISTRY; MORBIDITY; OCCULT BLOOD; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; PROGRAM EFFECTIVENESS; PUBLIC HEALTH SERVICE; SECONDARY HEALTH CARE; TERTIARY HEALTH CARE; AUSTRALIA; EARLY CANCER DIAGNOSIS; NEOPLASM; PUBLIC HEALTH;

AUSTRALIA; EARLY DETECTION OF CANCER; HUMANS; NATIONAL HEALTH PROGRAMS; NEOPLASMS;

EID: 84973529690     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12484     Document Type: Editorial

References (27)

1. Australian Institute of Health and Welfare and the Australian Government Department of Health. Analysis of colorectal cancer outcomes for the Australian National Bowel Cancer Screening Program. Asia Pac J Clin Oncol 2016; 12: 22-32.
2. Australian Institute of Health and Welfare. National Bowel Cancer Screening Program: monitoring report 2013-14. Canberra AIHW 2015. (AIHW Cat. No. CAN 92; Cancer Series 94).
3. Pignone MP, Flitcroft KL, Howard K et al. Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer. Med J Aust 2011; 194: 180-5.
4. Cenin DR, St John DJB, Ledger MJN et al. Optimising the expansion of the National Bowel Cancer Screening Program. Med J Aust 2014; 201: 456-61.
5. Bishop J, Glass P, Tracey E et al. Health Economics Review of Bowel Cancer Screening in Australia. Cancer Institute NSW, August 2008.
6. Olver I, Grogan P, Early success for Australia's bowel screening program: let's move it along. Med J Aust 2013; 198 (6): 300-1.
7. Appleyard M, Grimpen F, Spucches C et al. Participation in the national bowel cancer screening program and outcomes in Queensland. J Gastroenterol Hepatol 2011; 26 (Suppl 4): 29.
8. Ananda SS, McLaughlin SJ, Chen F et al. Initial impact of Australia's National Bowel Cancer Screening Program. Med J Aust 2009; 191: 378-81.
9. Cole SR, Tucker GR, Osborne JM et al. Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program. Med J Aust 2013; 198: 327-30.
10. Australian Institute of Health and Welfare, Cancer incidence projections, Australia 2011 to 2020, 2012.
11. Australian Bureau of Statistics, 3222.0 - Population Projections, Australia, 2012 (base) to 2101, 2013.
12. Australian Institute of Health and Welfare, Cancer in Australia: an overview 2014, 2015.
13. United Nations, ESCAP report, Population trends in Asia and the Pacific, 2013.
14. Australian Government Department of Health and Ageing. The Australian Bowel Cancer Screening Pilot Program and Beyond: Final evaluation report. Screening Monograph No.6/2005. Bowel Cancer Screening Pilot Monitoring and Evaluation Steering Committee October 2005.
15. Australian Institute of Health and Welfare, Australia's health system 2014, 2014.
16. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
17. Kronborg O, Fenger C, Olsen J et al. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 1996; 348: 1467-71
18. Steele RJC, McClements P, Watling C et al. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut 2012; 61: 576-81.
19. van Rossum LG, van Rijn AF, Laheij RJ et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008; 135: 82-90.
20. Guittet L, Guillaume E, Levillain R et al. Analytic comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 2011; 20: 1492-501.
21. Vilkin A, Rozen P, Levi Z et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical fecal occult blood screening test. Am J Gastroenterol 2005; 100: 2515-25.
22. Grazzini G, Visioli CB, Zorzi M et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 2009; 100: 259-65.
23. Grazzini G, Ventura L, Zappa M et al. Influence of seasonal variations in ambient temperature on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district. Gut 2010; 59: 1151-515.
24. van Rossum LGM, van Rijn AF, van Oijen MGH et al. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening. Int J Cancer 2009; 125: 746-50.
25. Hillyer GC, Neugut AI. Where does it FIT? The roles of fecal testing and colonoscopy in colorectal cancer screening. Cancer 2015; 121: 3186-9.
26. Australian Institute of Health and Welfare, National Bowel Cancer Screening Program: monitoring report 2013-14, 2015.
27. Australian Institute of Health and Welfare, Health system expenditure on cancer and other neoplasms in Australia: 2008-09, 2013.